We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Par Pharma Suit Tests FDA's Drug Pricing Pushback

Law360, New York (October 30, 2017, 8:30 PM EDT) -- Efforts by the U.S. Food and Drug Administration to combat dramatic price spikes for prescription drugs are being tested by a new Par Pharmaceutical lawsuit accusing regulators of improperly letting compounding...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.